JPRN-UMIN000002529已完成未知
Targeted radiotherapy for malignant neuroendocrine tumors with I-131 metaiodobenzylguanidine (MIBG) - Targeted radiotherapy for malignant neuroendocrine tumors with MIBG
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)pregnant female and feeding female 2)patients with disturbed consciousness 3)expected life interval less than 1 month 4)limited bone marrow capacity Hb<9.0, WBC count<3,000, platelet count <100,000 5)renal disorder GFR<30 ml/min/1.73 m2 6)risks for the central nerve system during treatment 7)in case that radiation safety cannot be secured. in case with uncontrolled symptoms that may require emergent medical cares. in case that understanding and cooperation cannot be obtained from family members. 8) when medical staff determine that treatment cannot be properly carried out.
研究者
相似试验
进行中（未招募）
不适用
Targeted radionuclide therapy of neuroendocrine tumours using 177Lu-DOTATATE combined with induced local tumour up-regulation of somatostatin receptor expression for increased tumour dosage and tumour to background ratio - NET Therapy 177Lu-DOTATATEEUCTR2012-000266-38-DKDepartment of Nuclear Medicine, Odense University Hospital50
已完成
2 期
Targeted radiotherapy for malignant neuroendocrine tumors with MIBGeuroendocrine tumorsneuroendocrine tumors, I-131 MIBG therapyD018358JPRN-jRCTs041190085Seigo Kinuya18
已完成
2 期
Targeted radiotherapy for malignant neuroendocrine tumors with MIBGMalignant neuroendocrine tumorsmalignant neuroendocrine tumors, I-131 MIBG therapyJPRN-jRCTs041180040Kinuya Seigo61
已完成
不适用
Combination Targeted Radiotherapy in Neuroendocrine TumorsNeuroendocrine TumorsNCT01099228David Bushnell2
招募中
1 期
ExclUsive endocRine therapy Or radiation theraPy for women aged =70 years with luminal A-like early stage breast cancer (EUROPA): a randomized phase 3 trialMedDRA version: 20.0Level: PTClassification code: 10006187Term: Breast cancer Class: 100000004864breast cancerCTIS2023-508094-88-00niversity Of Florence926